Microart Inc.
MCRT
Other OTC0.00
USD
- -
- -
ISIN
US59502C1027
CUSIP
59502C102
Return %
Stock
S&P500
1Y
0.00
18.85
3Y
1,900.00
64.56
5Y
1,900.00
71.64
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Mark Wood
- Sector
- Technology
- Industry
- Hardware, Equipment & Parts
- Address
- 2611 Office Tower Delray Beach FL United States of America L3R 6G2
- IPO Date
- Sep 22, 2010
- Website
- microart.ca
- Similar Companies
- Business
- Microart Inc. (MCRT) researches and develops innovative stem cell solutions and therapeutic applications of adult stem cells; the company develops and commercializes cell-based anti-aging research and cosmetic products; it also advances proprietary technology for diabetes treatment. Founded in 1980 and headquartered at 2611 Office Tower, Langham Place, Kowloon City, Kowloon, Hong Kong, Microart operates in the biotechnology and healthcare sectors, targeting anti-aging, cosmetics, and therapeutic markets with a focus on adult stem cell innovations. The company maintains a minimal market capitalization of approximately US$130 with no reported revenue or earnings in recent trailing twelve-month periods, reflecting its early-stage research emphasis. No major recent partnerships, acquisitions, funding rounds, product launches, or strategic shifts have been publicly disclosed within the last 1-2 years, underscoring a period of operational stability amid limited financial activity.